Cargando…
Effects of Therapeutic Hypothermia Combined with Other Neuroprotective Strategies on Ischemic Stroke: Review of Evidence
Ischemic stroke is a major cause of death and disability globally, and its incidence is increasing. The only treatment approved by the US Food and Drug Administration for acute ischemic stroke is thrombolytic treatment with recombinant tissue plasminogen activator. As an alternative, therapeutic hyp...
Autores principales: | Zhang, Zheng, Zhang, Linlei, Ding, Yuchuan, Han, Zhao, Ji, Xunming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988605/ https://www.ncbi.nlm.nih.gov/pubmed/29896438 http://dx.doi.org/10.14336/AD.2017.0628 |
Ejemplares similares
-
Combination of Therapeutic Hypothermia and Other Neuroprotective Strategies after An Ischemic Cerebral Insult#
por: Goossens, Joline, et al.
Publicado: (2014) -
Neuroprotective Effects of Early Hypothermia Induced by Phenothiazines and DHC in Ischemic Stroke
por: Han, Yun, et al.
Publicado: (2021) -
Synergistically Induced Hypothermia and Enhanced Neuroprotection by Pharmacological and Physical Approaches in Stroke
por: Zhang, Jun, et al.
Publicado: (2018) -
Neuroprotective Effects of Pharmacological Hypothermia on Hyperglycolysis and Gluconeogenesis in Rats after Ischemic Stroke
por: Guan, Longfei, et al.
Publicado: (2022) -
Evidence and opportunities of hypothermia in acute ischemic stroke: Clinical trials of systemic versus selective hypothermia
por: Huber, Christian, et al.
Publicado: (2019)